{"id":35091,"date":"2025-10-08T13:21:55","date_gmt":"2025-10-08T20:21:55","guid":{"rendered":"https:\/\/getheally.com\/patients\/news\/week-by-week-timeline-what-to-expect-during-your-first-three-months-on-zepbound-copy"},"modified":"2025-11-19T13:32:58","modified_gmt":"2025-11-19T21:32:58","slug":"what-happens-if-you-miss-a-dose-of-zepbound","status":"publish","type":"post","link":"https:\/\/getheally.com\/patients\/news\/what-happens-if-you-miss-a-dose-of-zepbound","title":{"rendered":"What Happens If You Miss a Dose of Zepbound?"},"content":{"rendered":"

Zepbound (tirzepatide) is a once-weekly injection that helps support healthy weight management. Because it\u2019s taken only once a week, it\u2019s easy to lose track or forget a dose now and then. The good news? If you miss a dose of Zepbound, it usually isn\u2019t a big deal \u2014 as long as you know what to do next.<\/p>\n

Active Ingredient: Tirzepatide<\/h4>\n

Tirzepatide<\/a> is a dual agonist \u2014 it activates GLP-1 receptors and<\/em> GIP (glucose-dependent insulinotropic polypeptide) receptors. The added GIP activity may enhance weight loss and blood sugar control compared to GLP-1\u2013only drugs.<\/p>\n

\n
\n\n\n\n\n\n\n
Brand Name<\/th>\nManufacturer<\/th>\nRoute<\/th>\nFDA-Approved Use<\/th>\nFDA Approval Year<\/th>\n<\/tr>\n<\/thead>\n
Mounjaro<\/a><\/td>\nEli Lilly<\/td>\nInjectable (weekly)<\/td>\nType 2 diabetes<\/td>\n2022<\/td>\n<\/tr>\n
Zepbound<\/a><\/td>\nEli Lilly<\/td>\nInjectable (weekly)<\/td>\nChronic weight management<\/td>\n2023<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
Throughout this article, any reference to Tirzepatide for weight loss refers to Zepbound. Mentions of Tirzepatide for blood sugar control refer to Mounjaro.<\/div>\n<\/div>\n<\/div>\n

Key Takeaways<\/h3>\n